DONNA ISFORT: Open Payments
NPI 1972684215 · IRVINE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 23 payments from 13 companies in 2025. Trend: 2023 $271 · 2024 $481 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 8 | $175 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: Haegarda, Andembry, TRELEGY ELLIPTA, Kerendia, VRAYLAR, ACCRUFER, GVOKE HYPOPEN, NURTEC ODT.
Industry payments across KY — which companies pay providers there.
